| Rod Mahmoudizad, MD | |
|
21800 Katy Fwy Ste 200, Katy, TX 77449-7780 | |
| (713) 771-1100 | |
| (713) 771-1545 |
| Full Name | Rod Mahmoudizad |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 13 Years |
| Location | 21800 Katy Fwy Ste 200, Katy, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992084735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | Q8950 (Texas) | Secondary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | Q8950 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pdp Of Texas, Pllc | 2466455050 | 57 |
| Michael Sonabend Md Pa | 6901045665 | 20 |
News Archive
Sequence differences in less than 0.2% of the 3-billion-base human genome play a vital role in a bewildering variety of human disease. Researchers from the Wellcome Trust Sanger Institute and the Cambridge University's Cambridge Institute for Medical Research, together with international colleagues report in PLoS Genetics their detailed maps of differences implicated in disease as well as genes that are unchanged in recent human history.
A webinar on JCAHO Emergency Department Core Measures: Achieving Successful Quality Outcomes is being presented by Compirion Healthcare Solutions to aid Hospital Emergency Departments in instituting treatment standards as defined by the Joint Commission, for AMI, CHA and CAP patients. Compliance with JCAHO Core Measures produces better outcomes for the patient while assuring maximum MSI reimbursement to the hospital.
A pair of new studies has provided new insight into the challenges faced by children on the autism spectrum who exhibit symptoms of attention deficit/hyperactivity disorder.
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan. 11-14, 2010.
InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis (MS).
› Verified 7 days ago
| Entity Name | Pdp Of Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629025739 PECOS PAC ID: 2466455050 Enrollment ID: O20060822000094 |
News Archive
Sequence differences in less than 0.2% of the 3-billion-base human genome play a vital role in a bewildering variety of human disease. Researchers from the Wellcome Trust Sanger Institute and the Cambridge University's Cambridge Institute for Medical Research, together with international colleagues report in PLoS Genetics their detailed maps of differences implicated in disease as well as genes that are unchanged in recent human history.
A webinar on JCAHO Emergency Department Core Measures: Achieving Successful Quality Outcomes is being presented by Compirion Healthcare Solutions to aid Hospital Emergency Departments in instituting treatment standards as defined by the Joint Commission, for AMI, CHA and CAP patients. Compliance with JCAHO Core Measures produces better outcomes for the patient while assuring maximum MSI reimbursement to the hospital.
A pair of new studies has provided new insight into the challenges faced by children on the autism spectrum who exhibit symptoms of attention deficit/hyperactivity disorder.
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan. 11-14, 2010.
InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis (MS).
› Verified 7 days ago
| Entity Name | Michael Sonabend Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952642738 PECOS PAC ID: 6901045665 Enrollment ID: O20130611000075 |
News Archive
Sequence differences in less than 0.2% of the 3-billion-base human genome play a vital role in a bewildering variety of human disease. Researchers from the Wellcome Trust Sanger Institute and the Cambridge University's Cambridge Institute for Medical Research, together with international colleagues report in PLoS Genetics their detailed maps of differences implicated in disease as well as genes that are unchanged in recent human history.
A webinar on JCAHO Emergency Department Core Measures: Achieving Successful Quality Outcomes is being presented by Compirion Healthcare Solutions to aid Hospital Emergency Departments in instituting treatment standards as defined by the Joint Commission, for AMI, CHA and CAP patients. Compliance with JCAHO Core Measures produces better outcomes for the patient while assuring maximum MSI reimbursement to the hospital.
A pair of new studies has provided new insight into the challenges faced by children on the autism spectrum who exhibit symptoms of attention deficit/hyperactivity disorder.
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan. 11-14, 2010.
InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis (MS).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rod Mahmoudizad, MD 21800 Katy Fwy Ste 200, Katy, TX 77449-7780 Ph: (713) 771-1100 | Rod Mahmoudizad, MD 21800 Katy Fwy Ste 200, Katy, TX 77449-7780 Ph: (713) 771-1100 |
News Archive
Sequence differences in less than 0.2% of the 3-billion-base human genome play a vital role in a bewildering variety of human disease. Researchers from the Wellcome Trust Sanger Institute and the Cambridge University's Cambridge Institute for Medical Research, together with international colleagues report in PLoS Genetics their detailed maps of differences implicated in disease as well as genes that are unchanged in recent human history.
A webinar on JCAHO Emergency Department Core Measures: Achieving Successful Quality Outcomes is being presented by Compirion Healthcare Solutions to aid Hospital Emergency Departments in instituting treatment standards as defined by the Joint Commission, for AMI, CHA and CAP patients. Compliance with JCAHO Core Measures produces better outcomes for the patient while assuring maximum MSI reimbursement to the hospital.
A pair of new studies has provided new insight into the challenges faced by children on the autism spectrum who exhibit symptoms of attention deficit/hyperactivity disorder.
Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan. 11-14, 2010.
InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis (MS).
› Verified 7 days ago
Connie Mengyan Wang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4603 Fm 1463 Rd Ste 100, Katy, TX 77494 Phone: 281-612-0050 | |
Dr. Adam J Czelusta, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21310 Provincial Blvd, Katy, TX 77450 Phone: 281-599-0404 Fax: 281-599-1655 | |
Uyen Ngoc Mui, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 23510 Kingsland Blvd Ste 110, Katy, TX 77494 Phone: 281-400-1224 Fax: 281-462-5036 | |
Danielle Sara Applebaum, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4603 Fm 1463 Rd Ste 100, Katy, TX 77494 Phone: 281-612-0050 | |
Dr. Sana Hashmi Zahiruddin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21310 Provincial Blvd, Katy, TX 77450 Phone: 281-599-0404 | |
Kelly Herne Duncan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 430 S Mason Rd, Suite 101, Katy, TX 77450 Phone: 281-392-3803 Fax: 281-392-2766 | |
Dr. Rani Michelle Cooper, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 23050 Westheimer Pkwy, Katy, TX 77494 Phone: 281-394-9500 Fax: 281-394-5350 |